GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration

Area of Science:

• Molecular biology
• Gerontology
• Muscle physiology

Background:

• Skeletal muscle regeneration declines with age, contributing to frailty.
• The precise role of myostatin and growth differentiation factor 11 (GDF11) in muscle regeneration remains controversial.
• Prior studies reported age-related decreases in GDF11 and beneficial effects of GDF11 treatment, but these findings lacked reproducibility.

Purpose of the Study:

• To re-evaluate the role of GDF11 in age-related skeletal muscle changes.
• To develop and utilize a specific assay for accurate GDF11 detection.
• To investigate the mechanistic effects of GDF11 on muscle regeneration and satellite cell function.

Main Methods:

• Development of a GDF11-specific immunoassay.
• Measurement of GDF11 serum levels in aged rats and humans.
• Analysis of GDF11 mRNA expression in rat muscle tissue.
• Assessment of GDF11 and myostatin signaling pathways (SMAD2/3 phosphorylation).
• In vivo studies on GDF11's effect on mouse muscle regeneration and satellite cell expansion.

Main Results:

• Previous claims of age-related GDF11 decrease and regenerative benefits were found irreproducible due to non-specific reagents.
• A novel GDF11-specific immunoassay revealed a trend toward increased GDF11 levels in aged rats and humans.
• GDF11 mRNA levels increased in aged rat muscle.
• Mechanistically, GDF11 and myostatin share signaling pathways, inhibiting myoblast differentiation.
• GDF11 significantly impaired muscle regeneration and reduced satellite cell expansion in mice.

Conclusions:

• GDF11's role in muscle regeneration is inhibitory, contrary to some recent reports.
• Age-related increases in GDF11, suggested by preliminary human data, present a potential therapeutic target.
• Pharmacologic blockade of GDF11 may offer a strategy to combat age-related sarcopenia.